Figure 3From: The in vitroeffect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumoursThe effect of gefitinib on tumour-derived cells from recurrent ovarian cancer (n = 13). Legend Some tumours show increased sensitivity (lower IndexSUM), while others show enhanced resistance (higher IndexSUM)Back to article page